Secretory breast carcinoma--case report and review of the medical literature.
Secretory breast carcinoma (SBC) is a rare type of invasive breast cancer. Since little is known about the biology of this rare tumour, it is useful to report every such case, in order to make as much information as possible available in the medical literature. We present the case of an 18-year-old woman with a SBC treated by mastectomy (Madden) and axillary node dissection (stage pT3N1M0) followed by chemotherapy (FEC regimen) and radiotherapy. The patient has meanwhile completed 4 years of follow-up with no evidence of recurrence. The authors review the literature and summarize relevant findings concerning definition, pathology, clinical picture, treatment, and follow-up.
Costa
N M
NM
Medical Oncology Department, Portuguese Institute of Oncology, Centre of Oporto, Rua Dr. António Bernardino de Almeida, Porto 4200-072, Portugal. nunomatoscosta@netcabo.pt
Rodrigues
H
H
Pereira
H
H
Pardal
F
F
Matos
E
E
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001365:Axilla; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology / Q000601:surgery*; D002277:Carcinoma / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology / Q000601:surgery*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008197:Lymph Node Excision; D008408:Mastectomy; D018714:Radiotherapy, Adjuvant; D016896:Treatment Outcome
D015251:Epirubicin; D003520:Cyclophosphamide; D005472:Fluorouracil